• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Ross S. Berkowitz, MD


  • Worley MJ, Joseph NT, Berkowitz RS, Goldstein DP.Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia.Int J Gynecol Cancer. 2014 Jun;24(5):941-5.
  • Worley MJ, Guseh SH, Rauh-Hain JA, Esselen KM, Muto MG, Feltmate CM, Berkowitz RS, Del Carmen MG, Schorge JO, Horowitz NS.What is the optimal treatment for obese patients with advanced ovarian carcinoma?.Am J Obstet Gynecol. 2014 Apr 1.
  • Conner JR, Meserve E, Pizer E, Garber J, Roh M, Urban N, Drescher C, Quade BJ, Muto M, Howitt BE, Pearlman MD, Berkowitz RS, Horowitz N, Crum CP, Feltmate C.Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations.Gynecol Oncol. 2014 Feb;132(2):280-6.
  • Esselen KM, Ng SK, Hua Y, White M, Jimenez CA, Welch WR, Drapkin R, Berkowitz RS, Ng SW.Endosalpingiosis as it relates to tubal, ovarian and serous neoplastic tissues: an immunohistochemical study of tubal and Müllerian antigens.Gynecol Oncol. 2014 Feb;132(2):316-21.
  • Viswanathan AN, Lee H, Berkowitz R, Berlin S, Campos S, Feltmate C, Horowitz N, Muto M, Sadow CA, Matulonis U.A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial cancer.Gynecol Oncol. 2014 Jan;132(1):55-60.
  • Merritt MA, Bentink S, Schwede M, Iwanicki MP, Quackenbush J, Woo T, Agoston ES, Reinhardt F, Crum CP, Berkowitz RS, Mok SC, Witt AE, Jones MA, Wang B, Ince TA.Gene expression signature of normal cell-of-origin predicts ovarian tumor outcomes.PLoS ONE. 2013;8(11):e80314.
  • Shoni M, Nagymanyoki Z, Vitonis AF, Jimenez C, Ng SW, Quade BJ, Berkowitz RS.p-21-Activated kinase-1, -4 and -6 and estrogen receptor expression pattern in normal placenta and gestational trophoblastic diseases.Gynecol Oncol. 2013 Dec;131(3):759-63.
  • Zhou S, Tang L, Wang H, Dai J, Zhang J, Shen L, Ng SW, Berkowitz RS.Overexpression of c-Abl predicts unfavorable outcome in epithelial ovarian cancer.Gynecol Oncol. 2013 Oct;131(1):69-76.
  • Greer AH, Yong T, Fennell K, Moustafa YW, Fowler M, Galiano F, Ng SW, Berkowitz RS, Cardelli J, Meyers S, Davis JN.Knockdown of core binding factorβ alters sphingolipid metabolism.J Cell Physiol. 2013 Dec;228(12):2350-64.
  • Viswanathan AN, Pinto AP, Schultz D, Berkowitz R, Crum CP.Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma.Gynecol Oncol. 2013 Sep;130(3):545-9.
  • Maestá I, Growdon WB, Goldstein DP, Bernstein MR, Horowitz NS, Rudge MV, Berkowitz RS.Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia.Gynecol Oncol. 2013 Aug;130(2):312-6.
  • May T, Yang J, Shoni M, Liu S, He H, Gali R, Ng SK, Crum C, Berkowitz RS, Ng SW.BRCA1 expression is epigenetically repressed in sporadic ovarian cancer cells by overexpression of C-terminal binding protein 2.Neoplasia. 2013 Jun;15(6):600-8.
  • Townamchai K, Berkowitz R, Bhagwat M, Damato AL, Friesen S, Lee LJ, Matulonis U, O'Farrell D, Viswanathan AN.Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer.Gynecol Oncol. 2013 Apr;129(1):18-21.
  • Worley MJ, Guseh SH, Rauh-Hain JA, Williams KA, Muto MG, Feltmate CM, Berkowitz RS, Horowitz NS.Does neoadjuvant chemotherapy decrease the risk of hospital readmission following debulking surgery?.Gynecol Oncol. 2013 Apr;129(1):69-73.
  • Rauh-Hain JA, Nitschmann CC, Worley MJ, Bradford LS, Berkowitz RS, Schorge JO, Campos SM, Del Carmen MG, Horowitz NS.Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma.Gynecol Oncol. 2013 Apr;129(1):63-8.
  • Worley MJ, Welch WR, Berkowitz RS, Ng SW.Endometriosis-associated ovarian cancer: a review of pathogenesis.Int J Mol Sci. 2013;14(3):5367-79.
  • McAuliffe SM, Morgan SL, Wyant GA, Tran LT, Muto KW, Chen YS, Chin KT, Partridge JC, Poole BB, Cheng KH, Daggett J, Cullen K, Kantoff E, Hasselbatt K, Berkowitz J, Muto MG, Berkowitz RS, Aster JC, Matulonis UA, Dinulescu DM.Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy.Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):E2939-48.
  • Wang ZC, Birkbak NJ, Culhane AC, Drapkin R, Fatima A, Tian R, Schwede M, Alsop K, Daniels KE, Piao H, Liu J, Etemadmoghadam D, Miron A, Salvesen HB, Mitchell G, Defazio A, Quackenbush J, Berkowitz RS, Iglehart JD, Bowtell DD, , Matulonis UA.Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome.Clin Cancer Res. 2012 Oct 15;18(20):5806-5815.
  • Saw YT, Yang J, Ng SK, Liu S, Singh S, Singh M, Welch WR, Tsuda H, Fong WP, Thompson D, Vasiliou V, Berkowitz RS, Ng SW.Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures.BMC Cancer. 2012;12:329.
  • Rodriguez N, Yang J, Hasselblatt K, Liu S, Zhou Y, Rauh-Hain JA, Ng SK, Choi PW, Fong WP, Agar NY, Welch WR, Berkowitz RS, Ng SW.Casein kinase I epsilon interacts with mitochondrial proteins for the growth and survival of human ovarian cancer cells.EMBO Mol Med. 2012 Sep;4(9):952-63.
  • Berkowitz RS, Goldstein DP.Current advances in the management of gestational trophoblastic disease.Gynecol Oncol. 2012 Jul 27.
  • Cheung TH, Man KN, Yu MY, Yim SF, Siu NS, Lo KW, Doran G, Wong RR, Wang VW, Smith DI, Worley MJ, Berkowitz RS, Chung TK, Wong YF.Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm.Cell Cycle. 2012 Aug 1;11(15):2876-84.
  • Fülöp V, Szigetvári I, Szepesi J, Végh G, Singh M, Berkowitz RS.Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years.J Reprod Med.;57(7-8):310-8.
  • Dantas PR, Maestá I, Cortés-Charry R, Growdon WB, Braga A, Rudge MV, Berkowitz RS.Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.J Reprod Med.;57(7-8):305-9.
  • Singh M, Kindelberger D, Nagymanyoki Z, Ng SW, Quick CM, Yamamoto H, Fichorova R, Fulop V, Berkowitz RS.Vascular endothelial growth factors and their receptors and regulators in gestational trophoblastic diseases and normal placenta.J Reprod Med.;57(5-6):197-203.
  • Berkowitz RS.Gestational trophoblastic disease: Presentations from the XVIth World Congress on Gestational Trophoblastic Diseases.J Reprod Med.;57(5-6):187-8.
  • Shah NT, Barroilhet L, Berkowitz RS, Goldstein DP, Horowitz N.A cost analysis of first-line chemotherapy for low-risk gestational trophoblastic neoplasia.J Reprod Med.;57(5-6):211-8.
  • Braga A, Growdon WB, Bernstein M, Maestá I, Rudge MV, Goldstein DP, Berkowitz RS.Molar pregnancy in adolescents.J Reprod Med.;57(5-6):225-30.
  • Elias KM, Shoni M, Bernstein M, Goldstein DP, Berkowitz RS.Complete hydatidiform mole in women aged 40 to 49 years.J Reprod Med.;57(5-6):254-8.
  • Rauh-Hain JA, Growdon WB, Braga A, Goldstein DP, Berkowitz RS.Gestational trophoblastic neoplasia in adolescents.J Reprod Med.;57(5-6):237-42.
  • Young JL, Koon EC, Kwong J, Welch WR, Muto MG, Berkowitz RS, Mok SC.Differential hRad17 expression by histologic subtype of ovarian cancer.Journal Of Ovarian Research. 2011 Mar 30;4(1):6.
  • Chung TK, Lau TS, Cheung TH, Yim SF, Lo KW, Siu NS, Chan LK, Yu MY, Kwong J, Doran G, Barroilhet LM, Ng AS, Wong RR, Wang VW, Mok SC, Smith DI, Berkowitz RS, Wong YF.Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1.Int J Cancer. 2011 Mar 11.
  • Gao Z, Xu X, McClane B, Zeng Q, Litkouhi B, Welch WR, Berkowitz RS, Mok SC, Garner EI.C Terminus of Clostridium perfringens Enterotoxin Downregulates CLDN4 and Sensitizes Ovarian Cancer Cells to Taxol and Carboplatin.Clin Cancer Res. 2011 Mar 1;17(5):1065-1074.
  • Rodriguez N, Goldstein DP, Berkowitz RS.Treating gestational trophoblastic disease.Expert Opin Pharmacother. 2010 Dec;11(18):3027-39.
  • Cramer DW, Vitonis AF, Welch WR, Terry KL, Goodman A, Rueda BR, Berkowitz RS.Correlates of the preoperative level of CA125 at presentation of ovarian cancer.Gynecol Oncol. 2010 Dec;119(3):462-8.
  • Ghosh S, Albitar L, LeBaron R, Welch WR, Samimi G, Birrer MJ, Berkowitz RS, Mok SC.Up-regulation of stromal versican expression in advanced stage serous ovarian cancer.Gynecol Oncol. 2010 Oct;119(1):114-20.
  • Seckl MJ, Sebire NJ, Berkowitz RS.Gestational trophoblastic disease.Lancet. 2010 Aug 28;376(9742):717-29. Review.
  • Growdon WB, Wolfberg AJ, Goldstein DP, Feltmate CM, Chinchilla ME, Lieberman ES, Berkowitz RS.Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.J Reprod Med.;55(7-8):279-84.
  • Berkowitz RS.Gestational trophoblastic disease. Presentations from the XVth World Congress on gestational trophoblastic diseases.J Reprod Med.;55(5-6):182-3.
  • Clark RM, Nevadunsky NS, Ghosh S, Goldstein DP, Berkowitz RS.The evolving role of hysterectomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center.J Reprod Med.;55(5-6):194-8.
  • Elias KM, Goldstein DP, Berkowitz RS.Complete hydatidiform mole in women older than age 50.J Reprod Med.;55(5-6):208-12.
  • Nagymanyoki Z, Kindelberger D, Clark R, Rodriguez N, Fulop V, Berkowitz RS.Age related cellular immune response against complete molar pregnancy.J Reprod Med.;55(5-6):261-6.
  • Fülöp V, Szigetvári I, Szepesi J, Végh G, Bátorfi J, Nagymányoki Z, Török M, Berkowitz RS.30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary.J Reprod Med.;55(5-6):253-7.
  • Seckl MJ, Savage PM, Hancock BW, Berkowitz RS, Goldstein DP, Lurain JR, Schink JC, Cagayan FM, Golfier F, Ngan H, Wake N, Osborne R, Sasaki S, Charry RC, Wong LC, Sekharan PK, Djamhoer MA, Massuger L, Belfort P, Kim SJ, Lee C, Jung SG."Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases".Gynecol Oncol. 2010 Jun;117(3):505-6; author reply 506-7.
  • Tang L, Yang J, Ng SK, Rodriguez N, Choi PW, Vitonis A, Wang K, McLachlan GJ, Caiazzo RJ, Liu BC, Welch WR, Cramer DW, Berkowitz RS, Ng SW.Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer.Eur J Cancer. 2010 Jan;46(1):170-9.
  • Xian W, Miron A, Roh M, Semmel DR, Yassin Y, Garber J, Oliva E, Goodman A, Mehra K, Berkowitz RS, Crum CP, Quade BJ.The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube.J Pathol. 2010 Jan;220(1):17-23.
  • Mok SC, Bonome T, Vathipadiekal V, Bell A, Johnson ME, Wong KK, Park DC, Hao K, Yip DK, Donninger H, Ozbun L, Samimi G, Brady J, Randonovich M, Pise-Masison CA, Barrett JC, Wong WH, Welch WR, Berkowitz RS, Birrer MJ.A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.Cancer Cell. 2009 Dec 8;16(6):521-32.
  • Kwong J,Chan FL,Wong KK,Birrer MJ,Archibald KM,Balkwill FR,Berkowitz RS,Mok SC.Inflammatory cytokine tumor necrosis factor alpha confers precancerous phenotype in an organoid model of normal human ovarian surface epithelial cells.Neoplasia. 2009 Jun;11(6):529-41.
  • Berkowitz RS,Goldstein DP.Clinical practice. Molar pregnancy.N Engl J Med. 2009 Apr 16;360(16):1639-45. Review.
  • Horowitz NS,Goldstein DP,Berkowitz RS.Management of gestational trophoblastic neoplasia.Semin Oncol. 2009 Apr;36(2):181-9. Review.
  • Growdon WB,Wolfberg AJ,Goldstein DP,Feltmate CM,Chinchilla ME,Lieberman ES,Berkowitz RS.Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.Gynecol Oncol. 2009 Feb;112(2):353-7.
  • Callahan MJ,Nagymanyoki Z,Bonome T,Johnson ME,Litkouhi B,Sullivan EH,Hirsch MS,Matulonis UA,Liu J,Birrer MJ,Berkowitz RS,Mok SC.Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer.Clin Cancer Res. 2008 Dec 1;14(23):7667-73.
  • Nevadunsky NS,Barbieri JS,Kwong J,Merritt MA,Welch WR,Berkowitz RS,Mok SC.RUNX3 protein is overexpressed in human epithelial ovarian cancer.Gynecol Oncol. 2009 Feb;112(2):325-30.
  • Ko EM,Muto MG,Berkowitz RS,Feltmate CM.Robotic versus open radical hysterectomy: a comparative study at a single institution.Gynecol Oncol. 2008 Dec;111(3):425-30.
  • Berkowitz RS,Goldstein DP.Current management of gestational trophoblastic diseases.Gynecol Oncol. 2009 Mar;112(3):654-62. Review.
  • Koon EC, Ma PC, Salgia R, Welch WR, Christensen JG, Berkowitz RS, Mok SC.Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion.Int J Gynecol Cancer.;18(5):976-84.
  • Nagymanyoki Z,Growdon WB,Sarno J,Callahan MJ,Parast MM,Fulop V,Mok SC,Horowitz N,Berkowitz RS.Vascularization and expression of angiogenic factors in partial and complete molar pregnancies.J Reprod Med. 2008 Aug;53(8):589-94.
  • Nagymanyoki Z,Callahan MJ,Parast MM,Fulop V,Mok SC,Berkowitz RS.Immune cell profiling in intraplacental and postmolar choriocarcinomas.J Reprod Med. 2008 Aug;53(8):558-64.
  • Nagymanyoki Z,Butler MO,Callahan MJ,Parast MM,Fulop V,Mok SC,Berkowitz RS.Antigen-specific T cell immune response detected by skewed T cell receptor usage in normal placenta and complete molar pregnancy.J Reprod Med. 2008 Jul;53(7):528-34.
  • Fulop V,Szigetvri I,Szepesi J,Torok M,Berkowitz RS.Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary.J Reprod Med. 2008 Jul;53(7):541-6.
  • Fleming EL,Garrett L,Growdon WB,Callahan M,Nevadunsky N,Ghosh S,Goldstein DP,Berkowitz RS.The changing role of thoracotomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center.J Reprod Med. 2008 Jul;53(7):493-8.
  • Garrett LA,Garner EI,Feltmate CM,Goldstein DP,Berkowitz RS.Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia.J Reprod Med. 2008 Jul;53(7):481-6.
  • Berkowitz RS,Goldstein DP.Gestational trophoblastic disease: presentations from the XLVTH World Congress on Gestational Trophoblastic Diseases.J Reprod Med. 2008 Jul;53(7):455-6.
  • Wong JY, Huggins GS, Debidda M, Munshi NC, De Vivo I.Dichloroacetate induces apoptosis in endometrial cancer cells.Gynecol Oncol. 2008 Jun;109(3):394-402.
  • Litkouhi B, Litkouhi B, Fleming E, Welch WR, Berkowitz RS, Birrer MJ, Mok SC.Overexpression of CEACAM6 in borderline and invasive mucinous ovarian neoplasms.Gynecol Oncol. 2008 May;109(2):234-9.
  • Hill SJ, Berkowitz R, Granter SR, Hirsch MS.Pagetoid lesions of the vulva: a collision between malignant melanoma and extramammary Paget disease.Int J Gynecol Pathol. 2008 Apr;27(2):292-6.
  • Medeiros F, Callahan MJ, Elvin JA, Dorfman DM, Berkowitz RS, Quade BJ.Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole.Int J Gynecol Pathol. 2008 Apr;27(2):247-51.
  • Mok SC,Kwong J,Welch WR,Samimi G,Ozbun L,Bonome T,Birrer MJ,Berkowitz RS,Wong KK.Etiology and pathogenesis of epithelial ovarian cancer.Dis Markers. 2007;23(5-6):367-76. Review.
  • Nagymanyoki Z, Callahan MJ, Parast MM, Berkowitz RS, Mok SC, Fulop V.Overexpression of laminin receptor 1 on decidual cells in partial and complete mole.Gynecol Oncol. 2008 Jan;108(1):121-5.
  • Nagymanyoki Z, Callahan MJ, Parast MM, Fulop V, Mok SC, Berkowitz RS.Immune cell profiling in normal pregnancy, partial and complete molar pregnancy.Gynecol Oncol. 2007 Nov;107(2):292-7.
  • Callahan MJ, Crum CP, Medeiros F, Kindelberger DW, Elvin JA, Garber JE, Feltmate CM, Berkowitz RS, Muto MG.Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.J Clin Oncol. 2007 Sep 1;25(25):3985-90.
  • Cramer DW, Welch WR, Berkowitz RS, Godleski JJ.Presence of talc in pelvic lymph nodes of a woman with ovarian cancer and long-term genital exposure to cosmetic talc.Obstet Gynecol. 2007 Aug;110(2 Pt 2):498-501.
  • Lee S, Garner EI, Welch WR, Berkowitz RS, Mok SC.Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma.Gynecol Oncol. 2007 Aug;106(2):311-7.
  • Birrer MJ, Johnson ME, Hao K, Wong KK, Park DC, Bell A, Welch WR, Berkowitz RS, Mok SC.Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas.J Clin Oncol. 2007 Jun 1;25(16):2281-7.
  • Litkouhi B, Kwong J, Lo CM, Smedley JG, McClane BA, Aponte M, Gao Z, Sarno JL, Hinners J, Welch WR, Berkowitz RS, Mok SC, Garner EI.Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin.Neoplasia. 2007 Apr;9(4):304-14.
  • Garner EI, Goldstein DP, Feltmate CM, Berkowitz RS.Gestational trophoblastic disease.Clin Obstet Gynecol. 2007 Mar;50(1):112-22. Review.
  • Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, Callahan MJ, Garner EO, Gordon RW, Birch C, Berkowitz RS, Muto MG, Crum CP.Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.Am J Surg Pathol. 2007 Feb;31(2):161-9.
  • Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz R, Winer E.Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.Psychooncology. 2007 Oct;16(10):895-903.
  • Nishimura S, Tsuda H, Ito K, Jobo T, Yaegashi N, Inoue T, Sudo T, Berkowitz RS, Mok SC.Differential expression of ABCF2 protein among different histologic types of epithelial ovarian cancer and in clear cell adenocarcinomas of different organs.Hum Pathol.;38:134-9.
  • Growdon WB, Wolfberg AJ, Feltmate CM, Goldstein DP, Genest DR, Chinchilla ME, Berkowitz RS, Lieberman ES.Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.J Reprod Med. 2006 Nov;51(11):871-4.
  • Feltmate CM, Growdon WB, Wolfberg AJ, Goldstein DP, Genest DR, Chinchilla ME, Lieberman ES, Berkowitz RS.Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy.J Reprod Med. 2006 Nov;51(11):902-6.
  • Szigetvri I, Szepesi J, Vgh G, Btorfi J, Arat G, Gti I, Berkowitz RS, Flp V.25 years' experience in the treatment of gestational trophoblastic neoplasia in Hungary.J Reprod Med. 2006 Oct;51(10):841-8.
  • Littell RD, Hallonquist H, Matulonis U, Seiden MV, Berkowitz RS, Duska LR.Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma.Gynecol Oncol. 2006 Nov;103(2):570-4.
  • Nishimura S, Tsuda H, Ito K, Jobo T, Yaegashi N, Inoue T, Sudo T, Berkowitz RS, Mok SC.Differential expression of ABCF2 protein among different histologic types of epithelial ovarian cancer and in clear cell adenocarcinomas of different organs.Hum Pathol. 2007 Jan;38(1):134-9.
  • Wolfberg AJ, Growdon WB, Feltmate CM, Goldstein DP, Genest DR, Chinchilla ME, Berkowitz RS, Lieberman ES.Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy.Obstet Gynecol. 2006 Aug;108(2):393-6.
  • Viswanathan AN, Lee H, Hanson E, Berkowitz RS, Crum CP.Influence of margin status and radiation on recurrence after radical hysterectomy in stage IB cervical cancer.Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1501-7.
  • Cole LA, Khanlian SA, Muller CY, Giddings A, Kohorn E, Berkowitz R.Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.Gynecol Oncol. 2006 Aug;102(2):160-4.
  • Kwong J, Lee JY, Wong KK, Zhou X, Wong DT, Lo KW, Welch WR, Berkowitz RS, Mok SC.Candidate Tumor-Suppressor Gene DLEC1 Is Frequently Downregulated by Promoter Hypermethylation and Histone Hypoacetylation in Human Epithelial Ovarian Cancer.Neoplasia. 2006 Apr;8(4):268-78.
  • Hashiguchi Y, Tsuda H, Bandera CA, Nishimura S, Inoue T, Kawamura N, Berkowitz RS, Mok SC.Comparison of osteopontin expression in endometrioid endometrial cancer and ovarian endometrioid cancer.Med Oncol. 2006;23(2):205-12.
  • Wamunyokoli FW, Bonome T, Lee JY, Feltmate CM, Welch WR, Radonovich M, Pise-Masison C, Brady J, Hao K, Berkowitz RS, Mok S, Birrer MJ.Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance.Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):690-700.
  • Ye B, Skates S, Mok SC, Horick NK, Rosenberg HF, Vitonis A, Edwards D, Sluss P, Han WK, Berkowitz RS, Cramer DW.Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.Clin Cancer Res. 2006 Jan 15;12(2):432-41.
  • Huang KC, Park DC, Ng SK, Lee JY, Ni X, Ng WC, Bandera CA, Welch WR, Berkowitz RS, Mok SC, Ng SW.Selenium binding protein 1 in ovarian cancer.Int J Cancer. 2006 May 15;118(10):2433-40.
  • Hashiguchi Y, Tsuda H, Inoue T, Berkowitz RS, Mok SC.PTEN expression in clear cell adenocarcinoma of the ovary.Gynecol Oncol. 2006 Apr;101(1):71-5.
  • Feltmate CM, Lee KR, Johnson M, Schorge JO, Wong KK, Hao K, Welch WR, Bell DA, Berkowitz RS, Mok SC.Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas.Clin Cancer Res. 2005 Nov 1;11(21):7651-7.
  • Tsuda H, Ito YM, Ohashi Y, Wong KK, Hashiguchi Y, Welch WR, Berkowitz RS, Birrer MJ, Mok SC.Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analyses.Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6880-8.
  • Garner EI, Feltmate CM, Goldstein DP, Berkowitz RS.The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey.Gynecol Oncol. 2005 Oct;99(1):3-5.
  • Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E.Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.Obstet Gynecol. 2005 Sep;106(3):548-52.
  • Cramer DW, Titus-Ernstoff L, McKolanis JR, Welch WR, Vitonis AF, Berkowitz RS, Finn OJ.Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer.Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1125-31.
  • Wenzel L, Dogan-Ates A, Habbal R, Berkowitz R, Goldstein DP, Bernstein M, Kluhsman BC, Osann K, Newlands E, Seckl MJ, Hancock B, Cella D.Defining and measuring reproductive concerns of female cancer survivors.J Natl Cancer Inst Monogr. 2005(34):94-8.
  • Duska LR, Berkowitz R, Matulonis U, Muto M, Goodman A, McIntyre JF, Klein A, Atkinson T, Seiden MV, Campos S.A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer.Gynecol Oncol. 2005 Jan;96(1):198-203.
  • Huddleston HG, Wong KK, Welch WR, Berkowitz RS, Mok SC.Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker.Gynecol Oncol. 2005 Jan;96(1):77-83.
  • Tsuda H, Birrer MJ, Ito YM, Ohashi Y, Lin M, Lee C, Wong WH, Rao PH, Lau CC, Berkowitz RS, Wong KK, Mok SC.Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform.Cancer Genet Cytogenet. 2004 Dec;155(2):97-107.
  • Penson RT, Seiden MV, Goodman A, Fuller AF, Berkowitz RS, Matulonis UA, Krasner C, Lee H, Atkinson T, Campos SM,.Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with mllerian malignancies.Gynecol Oncol. 2004 Jun;93(3):702-7.
  • Schorge JO, Drake RD, Lee H, Skates SJ, Rajanbabu R, Miller DS, Kim JH, Cramer DW, Berkowitz RS, Mok SC.Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer.Clin Cancer Res. 2004 May 15;10(10):3474-8.
  • Garner E, Goldstein DP, Berkowitz RS, Wenzel L.Psychosocial and reproductive outcomes of gestational trophoblastic diseases.Best Pract Res Clin Obstet Gynaecol. 2003 Dec;17(6):959-68.
  • Matulonis U, Campos S, Duska L, Fuller A, Berkowitz R, Gore S, Roche M, Colella T, Lee H, Seiden MV, ,.A phase II trial of three sequential doublets for the treatment of advanced mllerian malignancies.Gynecol Oncol. 2003 Nov;91(2):293-8.
  • Kim JH, Herlyn D, Wong KK, Park DC, Schorge JO, Lu KH, Skates SJ, Cramer DW, Berkowitz RS, Mok SC.Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer.Clin Cancer Res. 2003 Oct 15;9(13):4782-91.
  • Campos SM, Matulonis UA, Penson RT, Lee H, Berkowitz RS, Duska LR, Fuller AF, Wilson KS, Puchalski TA, Supko JG, Seiden MV.Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Mllerian tumors.Gynecol Oncol. 2003 Sep;90(3):610-8.
  • Ye B, Cramer DW, Skates SJ, Gygi SP, Pratomo V, Fu L, Horick NK, Licklider LJ, Schorge JO, Berkowitz RS, Mok SC.Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry.Clin Cancer Res. 2003 Aug 1;9(8):2904-11.
  • Batorfi J, Fulop V, Kim JH, Genest DR, Doszpod J, Mok SC, Berkowitz RS.Osteopontin is down-regulated in hydatidiform mole.Gynecol Oncol. 2003 Apr;89(1):134-9.
  • Feltmate CM, Batorfi J, Fulop V, Goldstein DP, Doszpod J, Berkowitz RS.Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation.Obstet Gynecol. 2003 Apr;101(4):732-6.
  • Batorfi J, Ye B, Mok SC, Cseh I, Berkowitz RS, Fulop V.Protein profiling of complete mole and normal placenta using ProteinChip analysis on laser capture microdissected cells.Gynecol Oncol. 2003 Mar;88(3):424-8.
  • Garner EI, Meyerovitz M, Goldstein DP, Berkowitz RS.Successful term pregnancy after selective arterial embolization of symptomatic arteriovenous malformation in the setting of gestational trophoblastic tumor.Gynecol Oncol. 2003 Jan;88(1):69-72.
  • Huang KC, Rao PH, Lau CC, Heard E, Ng SK, Brown C, Mok SC, Berkowitz RS, Ng SW.Relationship of XIST expression and responses of ovarian cancer to chemotherapy.Mol Cancer Ther. 2002 Aug;1(10):769-76.
  • Crum CP, Berkowitz RS.Human papillomaviruses. Applications, caveats and prevention.J Reprod Med. 2002 Jul;47(7):519-28; discussion 528-9.
  • O'Regan A, Fleming C, Seidman JD, Wallach RC, Mok SC, Skates SJ, Berkowitz RS, Cramer DW.Osteopontin as a biomarker for ovarian cancer.JAMA. 2002 Jun 26;287:3208-3210.
  • Genest DR, Ruiz RE, Weremowicz S, Berkowitz RS, Goldstein DP, Dorfman DM.Do nontriploid partial hydatidiform moles exist? A histologic and flow cytometric reevaluation of nontriploid specimens.J Reprod Med. 2002 May;47(5):363-8.
  • Fulop V, Mok SC, Gati I, Berkowitz RS.Recent advances in molecular biology of gestational trophoblastic diseases. A review.J Reprod Med. 2002 May;47(5):369-79.
  • Wenzel L, Berkowitz RS, Newlands E, Hancock B, Goldstein DP, Seckl MJ, Habbal R, Bernstein M, Kluhsman B, Kulchak-Rahm A, Strickland S, Higgins J.Quality of life after gestational trophoblastic disease.J Reprod Med. 2002 May;47(5):387-94.
  • Garrett AP, Garner EO, Goldstein DP, Berkowitz RS.Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience.J Reprod Med. 2002 May;47(5):355-62.
  • Garner EI, Lipson E, Bernstein MR, Goldstein DP, Berkowitz RS.Subsequent pregnancy experience in patients with molar pregnancy and gestational trophoblastic tumor.J Reprod Med. 2002 May;47(5):380-6.
  • Feltmate CM, Genest DR, Goldstein DP, Berkowitz RS.Advances in the understanding of placental site trophoblastic tumor.J Reprod Med. 2002 May;47(5):337-41.
  • Garner EI, Stokes EE, Berkowitz RS, Mok SC, Cramer DW.Polymorphisms of the estrogen-metabolizing genes CYP17 and catechol-O-methyltransferase and risk of epithelial ovarian cancer.Cancer Res. 2002 Jun 1;62(11):3058-62.
  • Kim JH, Skates SJ, Uede T, Wong Kk KK, Schorge JO, Feltmate CM, Berkowitz RS, Cramer DW, Mok SC.Osteopontin as a potential diagnostic biomarker for ovarian cancer.JAMA. 2002 Apr 3;287(13):1671-9.
  • Ortiz BH, Ailawadi M, Colitti C, Muto MG, Deavers M, Silva EG, Berkowitz RS, Mok SC, Gershenson DM.Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors.Cancer Res. 2001 Oct 1;61(19):7264-7.
  • Mok SC, Chao J, Skates S, Wong K, Yiu GK, Muto MG, Berkowitz RS, Cramer DW.Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.J Natl Cancer Inst. 2001 Oct 3;93(19):1458-64.
  • Penson RT, Supko JG, Seiden MV, Fuller AF, Berkowitz RS, Goodman A, Campos SM, MacNeill KM, Cook S, Matulonis UA.A Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent Mllerian tumors.Cancer. 2001 Sep 1;92(5):1156-67.
  • Feltmate CM, Genest DR, Wise L, Bernstein MR, Goldstein DP, Berkowitz RS.Placental site trophoblastic tumor: a 17-year experience at the New England Trophoblastic Disease Center.Gynecol Oncol. 2001 Sep;82(3):415-9.
  • Yiu GK, Chan WY, Ng SW, Chan PS, Cheung KK, Berkowitz RS, Mok SC.SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells.Am J Pathol. 2001 Aug;159(2):609-22.
  • Garrett AP, Lee KR, Colitti CR, Muto MG, Berkowitz RS, Mok SC.k-ras mutation may be an early event in mucinous ovarian tumorigenesis.Int J Gynecol Pathol. 2001 Jul;20(3):244-51.
  • Wang VW, Bell DA, Berkowitz RS, Mok SC.Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors.Cancer Res. 2001 May 15;61(10):4169-74.
  • Campos SM, Penson RT, Mays AR, Berkowitz RS, Fuller AF, Goodman A, Matulonis UA, Muzikansky A, Seiden MV.The clinical utility of liposomal doxorubicin in recurrent ovarian cancer.Gynecol Oncol. 2001 May;81(2):206-12.
  • Berkowitz RS, Tuncer ZS, Bernstein MR, Goldstein DP.Management of gestational trophoblastic diseases: subsequent pregnancy experience.Semin Oncol. 2000 Dec;27(6):678-85.
  • Benson CB, Genest DR, Bernstein MR, Soto-Wright V, Goldstein DP, Berkowitz RS.Sonographic appearance of first trimester complete hydatidiform moles.Ultrasound Obstet Gynecol. 2000 Aug;16(2):188-91.
  • Lu KH, Garber JE, Cramer DW, Welch WR, Niloff J, Schrag D, Berkowitz RS, Muto MG.Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy.J Clin Oncol. 2000 Jul;18(14):2728-32.
  • Huang LW, Garrett AP, Schorge JO, Muto MG, Bell DA, Welch WR, Berkowitz RS, Mok SC.Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum.Am J Clin Pathol. 2000 Jul;114(1):93-9.
  • Tuncer ZS, Vegh GL, Fulop V, Genest DR, Mok SC, Berkowitz RS.Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.Gynecol Oncol. 2000 Jun;77(3):389-93.
  • Huang LW, Garrett AP, Bell DA, Welch WR, Berkowitz RS, Mok SC.Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors.Gynecol Oncol. 2000 Jun;77(3):369-76.
  • Tung N, Berkowitz R, Matulonis U, Quartulli M, Seiden M, Kim Y, Niloff J, Cannistra SA.Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer.Gynecol Oncol. 2000 May;77(2):271-7.
  • Ng SW, Yiu GK, Liu Y, Huang LW, Palnati M, Jun SH, Berkowitz RS, Mok SC.Analysis of p73 in human borderline and invasive ovarian tumor.Oncogene. 2000 Apr 6;19(15):1885-90.
  • Huang LW, Garrett AP, Muto MG, Colitti CV, Bell DA, Welch WR, Berkowitz RS, Mok SC.Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum.Hum Pathol. 2000 Mar;31(3):367-73.
  • Garrett AP, Ng SW, Muto MG, Welch WR, Bell DA, Berkowitz RS, Mok SC.ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum.Gynecol Oncol. 2000 Apr;77(1):105-11.
  • Schorge JO, Muto MG, Lee SJ, Huang LW, Welch WR, Bell DA, Keung EZ, Berkowitz RS, Mok SC.BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis.Cancer Res. 2000 Mar 1;60(5):1361-4.
  • Bakri Y, al-Hawashim N, Berkowitz R.CSF/serum beta-hCG ratio in patients with brain metastases of gestational trophoblastic tumor.J Reprod Med. 2000 Feb;45(2):94-6.
  • Schorge JO, Miller YB, Qi LJ, Muto MG, Welch WR, Berkowitz RS, Mok SC.Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum.Gynecol Oncol. 2000 Mar;76(3):369-72.
  • Chan WY, Cheung KK, Schorge JO, Huang LW, Welch WR, Bell DA, Berkowitz RS, Mok SC.Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers.Am J Pathol. 2000 Feb;156(2):409-17.
  • Soto-Wright V, Goldstein DP, Bernstein MR, Berkowitz RS.The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D.Gynecol Oncol. 1997 Jan;64(1):156-9.
  • Montes M, Roberts D, Berkowitz RS, Genest DR.Prevalence and significance of implantation site trophoblastic atypia in hydatidiform moles and spontaneous abortions.Am J Clin Pathol. 1996 Apr;105(4):411-6.
  • Muto MG, Cramer DW, Tangir J, Berkowitz R, Mok S.Frequency of the BRCA1 185delAG mutation among Jewish women with ovarian cancer and matched population controls.Cancer Res. 1996 Mar 15;56(6):1250-2.
  • Tangir J, Muto MG, Berkowitz RS, Welch WR, Bell DA, Mok SC.A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer.Oncogene. 1996 Feb 15;12(4):735-40.
  • Soto-Wright V, Bernstein M, Goldstein DP, Berkowitz RS.The changing clinical presentation of complete molar pregnancy.Obstet Gynecol. 1995 Nov;86(5):775-9.
  • Rodabaugh KJ, Biggs RB, Qureshi JA, Barrett AJ, Welch WR, Bell DA, Berkowitz RS, Mok SC.Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors.Oncogene. 1995 Oct 5;11(7):1249-54.
  • Berkowitz RS, Bernstein MR, Harlow BL, Rice LW, Lage JM, Goldstein DP, Cramer DW.Case-control study of risk factors for partial molar pregnancy.Am J Obstet Gynecol. 1995 Sep;173(3 Pt 1):788-94.
  • Tsao SW, Mok SC, Fey EG, Fletcher JA, Wan TS, Chew EC, Muto MG, Knapp RC, Berkowitz RS.Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs).Exp Cell Res. 1995 Jun;218(2):499-507.
  • Mok SC, Kwok TT, Berkowitz RS, Barrett AJ, Tsui FW.Overexpression of the protein tyrosine phosphatase, nonreceptor type 6 (PTPN6), in human epithelial ovarian cancer.Gynecol Oncol. 1995 Jun;57(3):299-303.
  • Rodabaugh KJ, Blanchard G, Welch WR, Bell DA, Berkowitz RS, Mok SC.Detailed deletion mapping of chromosome 6q in borderline epithelial ovarian tumors.Cancer Res. 1995 May 15;55(10):2169-72.
  • Goldstein DP, Berkowitz RS.Current management of complete and partial molar pregnancy.J Reprod Med. 1994 Mar;39(3):139-46.